US Patent 12214017 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Novo Nordisk

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Novo Nordisk

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 2222 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
2222 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

28 All APIs, 19 USDMF, 6 CEP/COS, 3 NDC API

28 All APIs
19 USDMF
6 CEP/COS
3 NDC API

DEVELOPMENTS

1077 Drugs in Development

1077 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1008 FDF Dossiers, 82 FDA Orange Book, 764 Europe, 66 Canada, 32 Australia, 64 South Africa

1008 FDF Dossiers
82 FDA Orange Book
764 Europe
66 Canada
32 Australia
64 South Africa

REF. STANDARDS & IMPURITIES

2 Others

2 Others

INSPECTIONS & REGISTRATIONS

81 FDA, 1 EDQM, 1 Third-Party Audit

81 FDA
1 EDQM
1 Third-Party Audit

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 5NOVO

filter Patent Number Reset all filters

5 All

01 512214017

API Patent Reset all filters

5 All

01 5Blank

filter FDF Patent Reset all filters

5 All

01 5Y

filter Expiration Date Reset all filters

5 All

01 52038-08-24

01

NOVO

BePharma

Not Confirmed

NOVO

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-08-24

SEMAGLUTIDE

US Patent Number : 12214017

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 215256

Patent Use Code : U-3162

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-08-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

NOVO

BePharma

Not Confirmed

NOVO

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-08-24

SEMAGLUTIDE

US Patent Number : 12214017

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 215256

Patent Use Code : U-3162

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-08-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

NOVO

BePharma

Not Confirmed

NOVO

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-08-24

SEMAGLUTIDE

US Patent Number : 12214017

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 215256

Patent Use Code : U-3162

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-08-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

NOVO

BePharma

Not Confirmed

NOVO

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-08-24

SEMAGLUTIDE

US Patent Number : 12214017

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 215256

Patent Use Code : U-3162

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-08-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

NOVO

BePharma

Not Confirmed

NOVO

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-08-24

SEMAGLUTIDE

US Patent Number : 12214017

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 215256

Patent Use Code : U-3162

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-08-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.